PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT PREDICTIVE ONCOLOGY, Inc.Security Agreement • September 30th, 2025 • Predictive Oncology Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York
Contract Type FiledSeptember 30th, 2025 Company Industry JurisdictionTHIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, __________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ______________ 1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Predictive Oncology, Inc., a Delaware corporation (the “Company”), up to [*] shares of common stock, par value $0.01 per share (the “Common Stock”), of the Company (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Letter, dated as of May 14, 2024, as amended twice on February 18, 2025 and on June 1, 2025 and September
FORM OF PRE-FUNDED COMMON STOCK PURCHASE WARRANT PREDICTIVE ONCOLOGY, Inc.Security Agreement • September 30th, 2025 • Predictive Oncology Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York
Contract Type FiledSeptember 30th, 2025 Company Industry JurisdictionTHIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, __________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the effective date of Shareholder Approval (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”), to subscribe for and purchase from Predictive Oncology, Inc., a Delaware corporation (the “Company”), up to [*] shares of common stock, par value $0.01 per share (the “Common Stock”), of the Company (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
COMMON STOCK PURCHASE WARRANT PREDICTIVE ONCOLOGY, Inc.Security Agreement • September 30th, 2025 • Predictive Oncology Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York
Contract Type FiledSeptember 30th, 2025 Company Industry JurisdictionTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, DNA Holdings Venture, Inc. or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ______________ 1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Predictive Oncology, Inc., a Delaware corporation (the “Company”), up to [*] shares of common stock, par value $0.01 per share (the “Common Stock”), of the Company (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Strategic Advisor Agreement dated September [*], 2025, by and between the Company and the Holder.
FORM OF PRE-FUNDED COMMON STOCK PURCHASE WARRANT PREDICTIVE ONCOLOGY, Inc.Security Agreement • September 30th, 2025 • Predictive Oncology Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York
Contract Type FiledSeptember 30th, 2025 Company Industry JurisdictionTHIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, __________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”), to subscribe for and purchase from Predictive Oncology, Inc., a Delaware corporation (the “Company”), up to [*] shares of common stock, par value $0.01 per share (the “Common Stock”), of the Company (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).